Trial
NCT00794313
Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Oregon Health and Science University
Collaborators
—
Condition
Parkinson's Disease
Intervention
Amantadine 300 mg
Why stopped
Funding Ended
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-02-01